Table 2 Summary statistics by high and low whole-brain WML volume groups.
High | Low | p value | |
|---|---|---|---|
Clinical characteristics | |||
n | 54 | 54 | - |
Age (years)a | 73.52 (7.63) | 64.19 (7.60) | <0.001 |
Sex, female (%)b | 32 (59.26) | 31 (57.41) | 1.000 |
Scan type, 2D (%)b | 25 (46.30) | 15 (27.78) | 0.073 |
MMSEc | 29.00 [29.00,30.00] | 29.00 [28.00,30.00] | 0.300 |
GDS-15c | 2.00 [0.00,4.00] | 2.00 [1.00,4.00] | 0.526 |
PSQI total scorea | 6.39 (3.68) | 6.86 (3.86) | 0.530 |
BMIc | 27.30 [24.96,30.60] | 25.00 [21.99,29.43] | 0.030 |
Antidepressants (%)b | 13 (24.07) | 11 (20.75) | 0.857 |
CIRS-Gc | 5.00 [3.00,6.00] | 3.00 [2.00,6.00] | 0.063 |
Vascular risk index, (%)d | 0.813 | ||
0 | 18 (37.50) | 19 (35.85) | |
1 | 16 (33.33) | 22 (41.51) | |
2 | 11 (22.92) | 9 (16.98) | |
3 | 3 (6.25) | 3 (5.66) | |
Actigraphy derived measures | |||
Total sleep time (min) | 424.67 (69.61) | 448.57 (56.59) | 0.055 |
WASO (min) | 54.34 (43.98) | 46.04 (32.27) | 0.266 |
Inter-daily stability | 0.51 (0.13) | 0.55 (0.12) | 0.093 |
Intra-daily variability | 0.83 (0.22) | 0.78 (0.22) | 0.215 |
Relative amplitude | 0.89 [0.83,0.93] | 0.91 [0.86,0.94] | 0.078 |
L5 | 7.21 [4.32,11.91] | 6.12 [4.33,9.02] | 0.291 |
M10 | 124.02 (47.77) | 135.53 (47.14) | 0.210 |
L5 start time (24-h) | 1477.00 (86.41) | 1457.07 (53.65) | 0.153 |